# Nrxn1 Knock-out Longitudinal study monitoring the progression of any electrophysiological phenotype related to sensory processing in the Nrxn1α knock-out model. The study contains two data sets (raw): - Charaterization (folder: charact) contains: 4-hour recordings at 10 weeks and 22 weeks, VEP and AEP at 10, 14, 18 and 22 weeks of age. - Arbaclofen (folder: arbaclofen) contains: 24-hour recordings at 8 weeks and 22 weeks, cross-over study VEP and AEP with 2 mg/kg arbaclofen at 8 weeks and 22 weeks. #### File types The recordings were made in TainiLive. The recording files are of the .edf+ type, meta data is provided as .yaml files and screenshots of the recording logs are available containing the exact transmitter frequency of each recording. The 24-hour recordings contain data from motion sensors recorded with Spike2 (CED) as .smrx format. ## Characterization #### Electrode configuration Electrodes implanted bilaterally over visual (AP -4, ML +- 2.5) (ch 3 & 14) and auditory cortices (AP -2.5, ML +- 3.5) (ch 4 & 12) and unilaterally over PFC (AP 2.58 ML -1.57) (ch13). Two EMGs in neck muscles (ch 8 & 11) and reference over the cerebellum. #### Recording specifications Due to software updates during the study the sampling frequency is not the same in all recordings - Sampling frequency: 19525 Hz - Low-pass filter: 9700 Hz - High-pass filter: 0.35 Hz A few files were recorded with the sampling frequency: 2789.3 Hz - VEP 3: 55970, 55971, 55963, 55964 #### Genotypes The genotype of the animal is presented below: | Batch # | WT | Het | Hom | | -------- | -------- | -------- | -------- | | 1 | 51333 |51334 |51372 | | |51346 |51341 |51383 | | |51355 |51343 |51389 | | |51363 |51344 |51391e| | |51375 |51345 |51403 | | |51413 |51351 |51405 | | | |51352 | | | 2 |55970 |55949 |55948 | | |55979 |55963 |55964 | | |55984 |55983 |55971 | | | |55985 |55978 | | 3 |57738 |57767 |57737 | | |57753 |57781 |57752 | | |57760 | |57762 | | |57763 | |57766 | | |57782 | | | |Total n | 14 | 13 |13(14)| e - poor signal at last recording ## Arbaclofen study Longitudinal study of how acute administration of arbaclofen affect the Nrxn1α knock-out model. Arbaclofen (2 mg/kg) i saline was administered in a cross-over design at 8 weeks and 22 weeks of age. The data includes a dose adjustment pilot (folder: VEP/additional/dose-response) with doses 3 mg/kg and 4 mg/kg and VEP gating at 30 weeks (folder: VEP/additional/aging). #### Electrode configurations Electrode configuration was the same as above for most of the animals, but for animals: 74979,74980,74981,74983,75023 The electrode configuration was as follows: Electrodes implanted bilaterally over visual (AP -4, ML +- 2.5) (ch 14 & 4) and auditory cortices (AP -2.5, ML +- 3.5) (ch 13 & 5) and unilaterally over PFC (AP 2.58 ML -1.57) (ch 3). Two EMGs in neck muscles (ch 8 & 11) and ref over the cerebellum. #### Randomization First recording (visual and auditory) of first time point: - Arb: 75031, 74960, 74959, 74965, 74985, 74930, 74931, 74988, 74924, 74968, 75024 - Vehicle: 74979, 74980, 74981, 74983, 75032, 75033, 74958, 74966, 74967, 74986, 74989, 75023 - second recordings, vice versa First recording of second time point: - Arb: 74979, 75032, 75033, 74960, 74958, 74959, 74966, 74967, 74930, 74989, 74968 - Vehicle: 74980, 74981, 74983, 75031, 74965, 74985, 74931, 74988, 74924, 75024, 75023 - second recordings, vice versa #### Recording specifications - Sampling rate: 1084.7 Hz - Low-pass filter: 9700 Hz - High-pass filter: 0.35 Hz #### Genotypes | WT | Het | Hom | | --- | --- | --- | | 74959 | 74924 | 74930 | | 74967 | 74960 | 74931 | | 74968 | 74965 | 74958 | | 74986e| 74966 | 74981 | | 74988 | 74979 | 74983 | | 75024 | 74980 | 74985 | | | 74989 | 75023 | | | 75032 | 75031 | | | | 75033 | |n=6 | 8 | 9 | e - only first time point